Blood test breakthrough could end diagnostic confusion for serious inflammatory diseases
NCT ID NCT02143986
Summary
This study aims to improve how doctors tell the difference between several serious conditions that look very similar: adult-onset Still's disease, sepsis, and other severe inflammatory syndromes. Researchers will test a specific blood marker called 'glycosylated ferritin' in 60 patients to see if its pattern can act as a more accurate diagnostic fingerprint for each disease. The goal is to help patients get the correct diagnosis and treatment faster.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Brugmann University Hospital
RECRUITINGBrussels, 1020, Belgium
Contact Email: •••••@•••••
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.